<
Sanofer and Shi Weiya jointly split China Parkinson Market
Release time: 2016-09-09 & nbsp & nbsp & nbsp Source: Anonymous
  September 7,Schveiya announced that since October 1st, Senfei will be fully responsible for Schwitzon's anti -Parkinson's disease Taishida's distribution and medical promotion work in China,signed the "Exclusive Distribution Agreement" and "Exclusive Promotion Agreement",The top experts in the field of Parkinson's disease in my country established & ldquo;。
 
  Cooperation of both parties,Shi Chongde, the general manager of Schivia China, said frankly,Sanofi has been farming in China for many years of sales channels to better promote Tyshida。In addition,Sanofi Siwi Ya said both said,This cooperation hopes to change that China is still in a low cognitive degree、Low consultation rate、Low diagnostic rate & ldquo; Three low & rdquo; Status。
 
  Stake Sports BettingThere stake sports betting appare media reports in the industry,A few months ago,Taishida team members have resigned one after another,As of now,The remaining Taishida team will be merged into other promotional teams of Shiweiya。Some people in the industry commented,Taishida Sales is handed over to Shi Weiya responsible to better improve efficiency,Relieve the sales bottlenecks encountered by the current multinational pharmaceutical companies。
 
  Common Parkinson Market
 
  It is understood,Taishida is the world's first non -corner dopamine receptor agonist,1996 Introduction to China was introduced to China,China has more than one million Parkinson patients with this medicine。
 
  Schivia's sales in 2015 reached 3.9 billion euros,The total number of employees in the world exceeds 21,000。Schivia's main business is distributed in cardiovascular disease、Tumor、metabolic disease、Five major diseases including neuropsychological and rheumatism,Shi Weiya invested 25%of its turnover into product research and development through its non -profit foundation。
 
  Exclusive distribution promotion agreement signed by both parties,Shi Chongde, general manager of Schivia China,Strategic cooperation with Sanofi,Schivias will integrate the resources of high -quality products and disease management in Parkinson's field,Enrich the plan for medical workers during the clinical treatment of Parkinson's disease,Improve Parkinson's patients' drugs。
 
  Sanofi Siwi Ya said both said,This cooperation is to better serve Chinese patients。Professor Jiang Stake Sports BettingYuping, My stake betting appchief physician of the Department of Neurology, Fudan University, said to the 21st Century Business Herald reporter,Beijing Beijing、Xi'an、A survey of epidemiological diseases in the three places in Shanghai shows that Parkinson's disease is 1.7%,It is estimated that the number of new patients across the country will reach 100,000 or more every year,At present, the number of Parkinson patients in my country is about 2 million,& ldquo; Parkinson's disease not only seriously affects the quality of life of patients,And significantly increases the economic burden of patients' families。A study display,Parkinson's patients with an average annual expenditure of disease -related expenses account for 44.8%of the average annual income of the family。& rdquo;
 
  but,Parkinson's disease is still low cognitive in China、Low consultation rate、Low diagnostic rate & ldquo; Three low & rdquo; Status。According to an introduction,Parkinson's disease in my country is only 40%,The diagnosis rate is only 45%。& ldquo; The gap between doctors in various places for Parkinson's diagnosis and standardized treatment level is also very large,Effective acquisition channels for high -quality treatment drugs need to be improved。& rdquo; Professor Jiang Stake Sports BettingYuping, My stake betting appchief physician of the Department of Neurology, Affiliated to Huashan Hospital affiliated to Fudan University, pointed out。
 
  Multinational pharmaceutical companies kill each other and love each other
 
  an indisputable fact is,Sanofi's sales channel resources are one of the important reasons for Shi Weiya to choose with it。According to Peng Zhenke, general manager of Sanofi My stake betting appChina My stake betting appPharmaceutical Operation, I introduced to the 21st Century Business Herald.,Sanofi Group in Beijing、Tianjin、Shenyang、Jinan、Shanghai、Hangzhou、Nanjing、Wuhan、Chengdu、Guangzhou and Urumqi have a total of 11 regional branches,As of the end of 2015,Sanofi has more than 9,000 employees in China,It is particularly important that the Sanofi sales channel has sank to a county -level hospital,Covering more than 3,000 hospitals across the country。
 
  Stake Sports BettingThere stake sports betting appare media reports in the industry,A few months ago,Taishida team members have resigned one after another,As of now,The remaining Taishida team will be merged into other promotional teams of Shiweiya。
 
  and after the GSK incident,Major companies started to sell again、Transfer of its low profits、Aging product line,or cooperate with domestic pharmaceutical companies,Save more funds to the development of new products,And product sales are also adjusted。The sales team of major foreign pharmaceutical companies in the past three years has also been adjusted frequently,Like Shi Weiya and Sanofi joined forces to divide the market,In the future, you may be more。
 
  For this,Sanofi Chinese Pharmaceutical Operation General Manager Peng Zhenke said,Not only a fierce competition relationship between multinational pharmaceutical companies,More cooperation with each other。
 
  Facts,With the slow development of the traditional pharmaceutical market,multinational pharmaceutical companies increasingly attach importance to China's rapid development emerging market,A large number of newly developed and developed drugs were also introduced into China as soon as possible,Various multinational pharmaceutical companies have also increased their capital in China、Expansion at China production stake online sports bettingbase, Stake Sports Bettingetc.,Mutual competition is self -evident。